Pharmaceutical News and Articles

FDA Approves Leqembi (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

Zydus Announces USFDA Orphan Drug Designation to Usnoflast for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Ahmedabad, India, January 22, 2025 Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Desig

Findings From Pivotal Nipocalimab Phase 3 Study in a Broad Antibody Positive Population of People Living with Generalized Myasthenia Gravis (gMG) Published in The Lancet Neurology

SPRING HOUSE, Pa., (January 23, 2025) Johnson Johnson (NYSE JNJ) today announced The Lancet Neurology has published results from the pivotal Phase 3 study of ni

Novo Nordisk Successfully Completes Phase 1b/2a Trial with Subcutaneous Amycretin in People with Overweight or Obesity

Bagsv rd, Denmark, 24 January 2025 Novo Nordisk today announced topline results from a phase 1b 2a clinical trial with amycretin, a unimolecular GLP-1 and amyli

CIA Now Backs Lab Leak Theory for COVID-19, But Confidence Remains Low

After years of speculation, the CIA has weighed in yet again A lab leak is now considered the likely origin of the COVID pandemic. However, the agency admits it

Parental Sociodemographics Linked to Child MMR Vaccine Uptake

Parental sociodemographic characteristics and COVID-19 vaccination status are associated with measles-mumps-rubella (MMR) vaccination rates in the United States

Bird Flu Concerns Prompt New FDA Guidance on Raw Pet Food Safety

Reports of cats becoming seriously ill or dying after consuming raw pet food or milk tainted with the deadly bird flu virus have prompted the U.S. Food and Drug

Women Face Higher Risk for Long COVID

Women have a higher risk for developing long COVID than men, according to a study published online Jan. 22 in JAMA Network Open. Dimpy P. Shah, M.D., Ph.D., fro

Lower Cancer Survival Seen for Residence in Redlined Neighborhoods

For young individuals with cancer, residence in redlined neighborhoods is associated with lower survival at five and 10 years, according to a study published on

Updated Heart Disease, Stroke Statistics Presented for 2025

Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online Jan. 27 in Circulation. Seth